Immune therapeutic strategies for the senescent tumor microenvironment.

Tadahito Yasuda, Y Alan Wang

Brown Center for Immunotherapy, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA. [email protected] Center for Immunotherapy, Department of Medicine, Indiana University School of Medicine, Indianapolis, USA. [email protected]. · pubmed

Paper

Abstract

Senescent cells can either to promote immunosuppressive tumor microenvironment or facilitate immune surveillance. Despite the revolutionary impact of cancer immunotherapy, durable responses in solid tumors, particularly in advanced stages, remain limited. Recent studies have shed light on the influence of senescent status within the tumor microenvironment (TME) on therapy resistance and major efforts are needed to overcome these challenges. This review summarizes recent advancements in targeting cellular senescence, with a particular focus on immunomodulatory approaches on the hallmarks of cellular senescence.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper discusses the role of senescent cells in the tumor microenvironment and their influence on cancer immunotherapy, which is relevant to understanding cellular senescence as a hallmark of aging. However, it primarily focuses on cancer treatment rather than addressing the root causes of aging or lifespan extension. The advancements in targeting cellular senescence are noteworthy, but the overall impact on the field of longevity research is limited, as it does not propose significant breakthroughs in aging mechanisms themselves.

Author of this paper? Send a correction.